B-type natriuretic peptide and heart failure: what can we learn from clinical trials? - Wikidata - awgldk - TriplyDB

B-type natriuretic peptide and heart failure: what can we learn from clinical trials?

B-type natriuretic peptide and heart failure: what can we learn from clinical trials?

http://www.wikidata.org/entity/Q39007435

about

B-type natriuretic peptide and heart failure: what can we learn from clinical trials?

http://www.wikidata.org/entity/Q39007435

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

B-type natriuretic peptide and heart failure: what can we learn from clinical trials?

@en

B-type natriuretic peptide and heart failure: what can we learn from clinical trials?

@nl

type

label

B-type natriuretic peptide and heart failure: what can we learn from clinical trials?

@en

B-type natriuretic peptide and heart failure: what can we learn from clinical trials?

@nl

prefLabel

B-type natriuretic peptide and heart failure: what can we learn from clinical trials?

@en

B-type natriuretic peptide and heart failure: what can we learn from clinical trials?

@nl

P1433

Q39007435-344A2B70-27C0-43B0-A65C-4D24125A98D3

P1476

Q39007435-1BF77090-ACAF-43FB-BD0B-FC157EAF5646

P2093

Q39007435-22F3DE02-2F77-4B28-9D28-3E4ADD8A3EE9

Q39007435-41E35BC5-B857-4D38-8D8E-115B1B56D86A

Q39007435-47EE244B-B710-42DD-BCB5-0F7E89A45466

Q39007435-9CA1FB23-9328-481A-985C-3FCF5CC9B24E

Q39007435-DE1D0021-B718-46D6-A40C-D34E7FA6F45C

P2860

Q39007435-0A74D418-AF1E-48C4-AF10-AA385B676346

Q39007435-0C85B059-0D95-4CB1-B6CF-23B74ADDC43F

Q39007435-0EC067FA-AF88-40FC-B8B5-C43DB47CD0D9

Q39007435-184C1752-8090-4629-ABED-79CC93071C2B

Q39007435-20F697BA-B204-4A8C-8FD3-92ABF15E22BE

Q39007435-26324947-9B72-495E-B509-89E8BBE6164F

Q39007435-2E82FD50-A15D-4183-AEC2-146ED82579EF

Q39007435-2F61B49E-8D51-40FE-964B-1D8FF8C847DE

Q39007435-379492A5-093B-4814-AD4D-072483A1DF95

Q39007435-39FBF0F9-8D5C-4D06-B1DC-57F34798DB34

P304

Q39007435-8F51372E-E78D-4263-98C4-0F8424017490

P31

Q39007435-A96DFBFB-8F50-4647-BB20-60AE7F6795A8

P356

Q39007435-B083234F-B32E-4742-BBDA-912876EC4BC5

P433

Q39007435-3B6F4971-2313-4110-BD08-264469AC8E29

P478

Q39007435-12F9E796-0CAC-469A-91FE-EE1EED1952FA

P50

Q39007435-C98DD6BA-DCC9-48C2-864C-FB751A36BB2D

P577

Q39007435-B754DBB4-68B3-4FEF-B921-015BE24E9C6E

P5875

Q39007435-C0A2B643-7FE8-4A07-AAE1-CAB92FA547E0

P698

Q39007435-CA483FA7-20A3-45BF-9D65-8C4E990FD33A

P356

1440-1681.12418

P1433

Clinical and Experimental Pharmacology and Physiology

P1476

B-type natriuretic peptide and heart failure: what can we learn from clinical trials?

@en

P2093

Angelo Andreas

http://www.w3.org/2001/XMLSchema#string

Christian Binoun-A-Egom

http://www.w3.org/2001/XMLSchema#string

Jan Klimas

http://www.w3.org/2001/XMLSchema#string

Peter Kruzliak

http://www.w3.org/2001/XMLSchema#string

Vanda Valentova

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of nesiritide in patients with acute decompensated heart failure

Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials

Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes

Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B.

Natriuretic peptide receptor-C regulates coronary blood flow and prevents myocardial ischemia/reperfusion injury: novel cardioprotective role for endothelium-derived C-type natriuretic peptide

Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure.

Beta-adrenergic receptor-G protein-adenylyl cyclase signal transduction in the failing heart.

How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review

Adjuvant cardioprotection in cardiac surgery: update.

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

P304

881-887

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1440-1681.12418

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-05-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276280795

http://www.w3.org/2001/XMLSchema#string

P698

25969125

http://www.w3.org/2001/XMLSchema#string